Works matching IS 02698811 AND DT 2008 AND VI 22 AND IP 2S

Results: 14

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 70, doi. 10.1177/0269881107088439

By:

O'Keane, Veronica

Publication type:

Article

The impact of hyperprolactinaemia on sexual function in patients with psychosis.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 63, doi. 10.1177/0269881107088438

By:

Smith, Shubulade M

Publication type:

Article

Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 56, doi. 10.1177/0269881107088436

By:

Bushe, Chris;
Yeomans, David;
Floyd, Tamsin;
Smith, Shubulade M

Publication type:

Article

A review of the association between antipsychotic use and hyperprolactinaemia.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 46, doi. 10.1177/0269881107088435

By:

Bushe, Chris;
Shaw, Michael;
Peveler, Robert C

Publication type:

Article

The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 3, doi. 10.1177/0269881107088434

By:

Dursun, Serdar M;
Wildgust, Hiram Joseph;
Strickland, Paul;
Goodwin, Guy M;
Citrome, Leslie;
Lean, Mike

Publication type:

Article

Understanding osteoporosis.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 38, doi. 10.1177/0269881107087955

By:

Javaid, M Kassim;
Holt, Richard IG

Publication type:

Article

Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 28, doi. 10.1177/0269881107087951

By:

Holt, Richard IG

Publication type:

Article

Current guidelines and their recommendations for prolactin monitoring in psychosis.

Published in:

2008

By:

Citrome, Leslie

Publication type:

journal article

Antipsychotics and hyperprolactinaemia: Clinical recommendations.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 98, doi. 10.1177/0269881107087346

By:

Peveler, Robert C;
Branford, David;
Citrome, Leslie;
Fitzgerald, Peter;
Harvey, Philip W;
Holt, Richard IG;
Howard, Louise;
Kohen, Dora;
Jones, Ian;
O'Keane, Veronica;
Pariente, Carmine M;
Pendlebury, John;
Smith, Shubulade M;
Yeomans, David

Publication type:

Article

Clinical questions and uncertainty--prolactin measurement in patients with schizophrenia and bipolar disorder.

Published in:

2008

By:

Walters, James;
Jones, Ian

Publication type:

journal article

Adverse effects of prolactin in rodents and humans: breast and prostate cancer.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 20, doi. 10.1177/0269881107082624

By:

Harvey, Philip W.;
Everett, David J.;
Springall, Christopher J.

Publication type:

Article

Prolactin and dopamine: What is the connection? A Review Article.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 12, doi. 10.1177/0269216307087148

By:

Fitzgerald, Peter;
Dinan, Timothy G

Publication type:

Article

The evolution of hyperprolactinaemia as an entity in psychiatric patients.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 6, doi. 10.1177/0269216307087147

By:

Kohen, Dora;
Wildgust, Hiram Joseph

Publication type:

Article

Pituitary volume in psychosis: the first review of the evidence.

Published in:

Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 76, doi. 10.1177/0269881107084020

By:

Pariante, Carmine M.

Publication type:

Article